This study was conducted to investigate CSF levels of insulin/IGF1, glucose/lactate, and Aβ42 between nonsmokers and active smokers to explore whether the changes of cerebral insulin sensitivity contribute to the AD risk in active smokers. This evidence concerns the gene IGF1 and Alzheimer disease.